Literature DB >> 28789423

TGF-β induces growth suppression in multiple myeloma MM.1S cells via E2F1.

Xialei Liu1, Hui Guo2, Yuting Wei3, Chaonong Cai1, Baimeng Zhang1, Jian Li1.   

Abstract

Transforming growth factor-β (TGF-β) has an important role in multiple target genes and signaling pathways. The E2F family of transcription factors is a group of DNA-binding proteins that are involved in cell-cycle progression, and therefore have a key role in proliferation. The present study demonstrates that inhibition of cell growth by TGF-β occurs in the multiple myeloma cell line MM.1S. However, the growth-suppressive effects of TGF-β may be reversed by small interfering (si)RNA to reduce the expression of E2F1. TGF-β1 and E2F1 siRNA were manipulated in MM.1S cells to investigate the association between these genes. FACScan Flow Cytometer, western blot analysis and other methods were adopted to confirm such interrelation. The present data showed that TGF-β mediated growth suppression in MM.1S cells, while inducing E2F1 protein expression levels rapidly and transiently. The present data support the hypothesis that E2F1 is a central mediator of TGF-β-induced growth suppression in MM.1S cells and control of E2F1 may be a downstream event of TGF-β action, at least in one multiple myeloma cell line.

Entities:  

Keywords:  E2F1; MM.1S cell line; TGF-β; cell viability; siRNA

Year:  2017        PMID: 28789423      PMCID: PMC5529755          DOI: 10.3892/ol.2017.6360

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  E2F-1 functions in mice to promote apoptosis and suppress proliferation.

Authors:  S J Field; F Y Tsai; F Kuo; A M Zubiaga; W G Kaelin; D M Livingston; S H Orkin; M E Greenberg
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

2.  Differentiation plasticity regulated by TGF-beta family proteins in development and disease.

Authors:  Rik Derynck; Rosemary J Akhurst
Journal:  Nat Cell Biol       Date:  2007-09       Impact factor: 28.824

Review 3.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

4.  Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program.

Authors:  C R Chen; Y Kang; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression.

Authors:  J K Schwarz; C H Bassing; I Kovesdi; M B Datto; M Blazing; S George; X F Wang; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

6.  Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor.

Authors:  A Hata; G Lagna; J Massagué; A Hemmati-Brivanlou
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

7.  Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

Authors:  A V Bakin; A K Tomlinson; N A Bhowmick; H L Moses; C L Arteaga
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 8.  Endocytic regulation of TGF-beta signaling.

Authors:  Ye-Guang Chen
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

Review 9.  Life and death decisions by E2F-1.

Authors:  L A Bell; K M Ryan
Journal:  Cell Death Differ       Date:  2004-02       Impact factor: 15.828

10.  p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration.

Authors:  Andrei V Bakin; Cammie Rinehart; Anne K Tomlinson; Carlos L Arteaga
Journal:  J Cell Sci       Date:  2002-08-01       Impact factor: 5.285

View more
  3 in total

Review 1.  New agents in the Treatment of Myeloma Bone Disease.

Authors:  Elizabeth S Ring; Michelle A Lawson; John A Snowden; Ingrid Jolley; Andrew D Chantry
Journal:  Calcif Tissue Int       Date:  2017-11-02       Impact factor: 4.333

2.  SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma.

Authors:  Jian Wu; Min Zhang; Omar Faruq; Eldad Zacksenhaus; Wenming Chen; Aijun Liu; Hong Chang
Journal:  Biomark Res       Date:  2021-06-16

3.  Long Noncoding RNA LUCAT1 Promotes Multiple Myeloma Cell Growth by Regulating the TGF-β Signaling Pathway.

Authors:  Zhaoyu Liu; Hong Gao; Qing Peng; Yongheng Yang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.